DrugBiological
Tetrodotoxin clinical trials
Also written TTX.
- studies test it
- 7
- open now
- 0
- in phase 3
- 2
- first study started
- 2008
How studies write it
Studies that test it under each name
Name
Development codes
- TTX
- 2
Studies by the year they started
7 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
- Pain
- 1
Who runs them
Industry 7 · Other 0
Wex Pharmaceuticals Inc. (6) · Dogwood Therapeutics Inc. (1)
Studies
Open first, then newest update. How each study uses Tetrodotoxin is read from its arms, and is right about nine times in ten.
Testing it · 7
- Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainActive, not recruitingPhase 2Dogwood Therapeutics Inc.NCT06848348Written as Halneuron
- A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic PainTerminatedPhase 2Wex Pharmaceuticals Inc.NCT05359133Written as Tetrodotoxin
- A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult SubjectsCompletedPhase 1Wex Pharmaceuticals Inc.NCT04083833Written as Tetrodotoxin
- The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy TreatmentTerminatedPhase 2Wex Pharmaceuticals Inc.NCT01655823Written as Tetrodotoxin
- Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related PainCompletedPhase 3Wex Pharmaceuticals Inc.NCT00725114Written as Tetrodotoxin
- Tetrodotoxin Open-label Efficacy and Safety Continuation StudyCompletedPhase 3Wex Pharmaceuticals Inc.NCT00726011Written as Tetrodotoxin
- Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy VolunteersCompletedPhase 1Wex Pharmaceuticals Inc.NCT01527734Written as Tetrodotoxin
Codes
What other systems call Tetrodotoxin · ClinicalTrials.gg INT008298
- MeSH (NLM) D013779TetrodotoxinOne source ClinicalTrials.gov
- UNII (FDA) 3KUM2721U9TETRODOTOXINOne source FDA
- NCI Thesaurus C78845TetrodotoxinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013779 | Tetrodotoxin | One source ClinicalTrials.gov |
| UNII (FDA) | 3KUM2721U9 | TETRODOTOXIN | One source FDA |
| NCI Thesaurus | C78845 | Tetrodotoxin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.